DD295990A5 - Waessriges doxorubicin - Google Patents

Waessriges doxorubicin Download PDF

Info

Publication number
DD295990A5
DD295990A5 DD89335266A DD33526689A DD295990A5 DD 295990 A5 DD295990 A5 DD 295990A5 DD 89335266 A DD89335266 A DD 89335266A DD 33526689 A DD33526689 A DD 33526689A DD 295990 A5 DD295990 A5 DD 295990A5
Authority
DD
German Democratic Republic
Prior art keywords
solution
doxorubicin
range
physiologically acceptable
water
Prior art date
Application number
DD89335266A
Other languages
German (de)
English (en)
Inventor
Murray A Kaplan
Robert K Perrone
Joseph B Bogardus
Original Assignee
�������`�����@������@�������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������`�����@������@�������k�� filed Critical �������`�����@������@�������k��
Publication of DD295990A5 publication Critical patent/DD295990A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Lubricants (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
DD89335266A 1988-12-05 1989-12-05 Waessriges doxorubicin DD295990A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27962788A 1988-12-05 1988-12-05

Publications (1)

Publication Number Publication Date
DD295990A5 true DD295990A5 (de) 1991-11-21

Family

ID=23069771

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89335266A DD295990A5 (de) 1988-12-05 1989-12-05 Waessriges doxorubicin

Country Status (20)

Country Link
EP (1) EP0372888B1 (pt)
JP (1) JPH02200637A (pt)
KR (1) KR920001460B1 (pt)
AT (1) ATE78402T1 (pt)
AU (1) AU612916B2 (pt)
DD (1) DD295990A5 (pt)
DE (1) DE68902223T2 (pt)
DK (1) DK609889A (pt)
ES (1) ES2044148T3 (pt)
FI (1) FI895733A0 (pt)
GR (1) GR3005391T3 (pt)
HU (1) HU204704B (pt)
IE (1) IE893867L (pt)
IL (1) IL92541A0 (pt)
NO (1) NO894811L (pt)
NZ (1) NZ231602A (pt)
OA (1) OA09898A (pt)
PT (1) PT92483B (pt)
YU (1) YU226189A (pt)
ZA (1) ZA899248B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
US11213538B2 (en) 2016-02-16 2022-01-04 General Incorporated Association Pharma Valley Project Supporting Organization Agent for overcoming immunosuppression and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.

Also Published As

Publication number Publication date
KR900009081A (ko) 1990-07-02
ZA899248B (en) 1990-08-29
PT92483B (pt) 1995-08-09
ES2044148T3 (es) 1994-01-01
PT92483A (pt) 1990-06-29
OA09898A (fr) 1994-09-15
NZ231602A (en) 1991-12-23
HUT52961A (en) 1990-09-28
AU4591589A (en) 1990-06-07
AU612916B2 (en) 1991-07-18
NO894811L (no) 1990-06-06
EP0372888B1 (en) 1992-07-22
HU896426D0 (en) 1990-02-28
ATE78402T1 (de) 1992-08-15
FI895733A0 (fi) 1989-11-30
DK609889A (da) 1990-06-06
DE68902223T2 (de) 1993-01-14
KR920001460B1 (ko) 1992-02-14
EP0372888A1 (en) 1990-06-13
NO894811D0 (no) 1989-12-01
YU226189A (en) 1991-02-28
GR3005391T3 (pt) 1993-05-24
IE893867L (en) 1990-06-05
JPH02200637A (ja) 1990-08-08
IL92541A0 (en) 1990-08-31
DE68902223D1 (de) 1992-08-27
DK609889D0 (da) 1989-12-04
HU204704B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
DE69913138T2 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
DE69005992T2 (de) Psychotropische Wirkstoffe enthaltende stabilisierte Lösungen.
DE69824277T2 (de) Stabile medizinische zusammenstellungen die 4,5-epoxymorphinanderivate enthalten
DE60011589T2 (de) Hochwirksame dihydroergotaminhaltige arzneizusammensetzungen
CH694396A5 (de) Pharmazeutische Zusammensetzung mit therapeutischem oder pharmazeutischem Mittel und Edetat.
DE102006056458A1 (de) Arzneimittelzubereitung von Tramadol und Acetaminophen
DE60025627T2 (de) Pharmazeutische lösung von levosimendan
DE2620483A1 (de) Stabile waessrige insulinloesungen
DE69004066T2 (de) Verfahren zur photostabilisierung von augenspüllösungen.
DE3042332A1 (de) Waessrige nitroglycerinloesung
DE69003906T2 (de) Triacetin enthaltende, langwirkende injizierbare Zusammensetzungen.
DE60305687T2 (de) Wässrige injizierbare Suspensionen für Tiere enthaltend Florfenicol
DE60117467T2 (de) Famotidin-injektionen
DE69819770T2 (de) Anästhetikum
CH676549A5 (pt)
DE2425281A1 (de) Pharmazeutische zusammensetzung
DE3751589T2 (de) Anthracyclin-Glucosid enthaltende einspritzbare gebrauchsfertige Lösungen gegen Krebs.
DD295990A5 (de) Waessriges doxorubicin
DE3876160T2 (de) Nichtwaessrige loesung von doxorubicinhydrochlorid.
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE69016087T2 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
EP2142169B1 (de) Wässrige pharmazeutische zubereitung
DE3136282A1 (de) "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
DE1467749A1 (de) Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee